| COS Unique Id: |
107548 |
| Title: |
Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 16, 2008
October 16, 2008
February 16, 2009
|
| Deadline Note: |
This program announcement expires on March 17, 2010. |
| Upper Amount: |
$275,000 |
| Amount Note: |
This funding opportunity will use the National
Institutes of Health (NIH) Exploratory/Developmental Research Grant
(R21). Direct costs are limited to $275,000 over the two years of the
R21 award, with no more than $200,000 in direct costs allowed in any
single year. Applicants may request direct costs in $25,000 modules, up
to the total direct costs limitation of $275,000 for the combined
two-year award period. |
| Eligibility: |
Applications may be submitted by domestic or
foreign, for-profit or nonprofit, public or private institutions, such
as universities, colleges, hospitals, and laboratories; units of state
and local government; eligible agencies of the federal government; and
faith-based or community-based organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The goal of this funding opportunity announcement
(FOA) is to foster exploratory and developmental research on important
topics in nutrition and cancer prevention through use of the NIH R21
mechanism. Specifically, this initiative seeks to promote cancer
prevention research focused on the identification and characterization
of molecular targets for bioactive food components. A bioactive food
component is defined as a dietary constituent that has a health benefit
by altering one or more cellular processes when provided in quantities
over and beyond that needed for basic nutrition.
The importance
of diet in cancer prevention was highlighted in the 2007 National
Cancer Institute (NCI) Bypass Budget. This special notation stemmed
from reports that a variety of dietary components spanning the gamut of
essential and non-essential food components can modify cancer risk and
tumor behavior. Research continues to provide evidence for
unprecedented opportunities for the expanded use of bioactive food
components as a strategy for cancer prevention. Although there is
substantial evidence suggesting that there are meaningful linkages
between diet and cancer risk, it remains unclear what food components
account for the protection and which cellular processes are critically
involved. A greater understanding of specific molecular targets for
individual bioactive food components is fundamental for the development
of effective, tailored, and "pre-emptive" nutritional strategies for
reducing cancer in humans.
Given the dollar and time limits
inherent for any R21 award, applications may involve proposals to study
either the identification of active food constituents or the
characterization of their sites of action (molecular targets), but a
study of both would likely be considered too broad. Investigators may
choose from the full range of preclinical or clinical approaches, but
should focus on either identifying and characterizing molecular targets
for known bioactive food components involved with cancer prevention; or
evaluating the bioactive food components for known targets. Since
various cancer processes can be influenced by transcriptional,
translational, and post-translational mechanisms, the use of a variety
of genomic, proteomic, and metabolomic technologies are appropriate.
Resources containing biomolecular data, such as gene, protein, and
metabolome databases, may be efficiently utilized to expedite research.
Bioinformatic approaches may also be used to identify patterns of gene,
protein, or metabolite changes that can generate unique fingerprints
for the given dietary treatments. |
| Contact Name: |
Barbara Liesenfeld |
| Contact Address: |
Office of Grants Administration
National Cancer Institute
6120 Executive Boulevard, EPS Room 243, MSC 7150 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-7150 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 496-3265 |
| Contact Fax: |
+1 (301) 846-5720 |
| Contact Email: |
liesenfb@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PA-07-362.html |
| Date Last Revised: |
April 1, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=107548 |
| Keywords: |
Cancer Prevention
Food Chemistry
Food Sciences
|
| Sponsor Reference No: |
PA-07-362 |
| Funding Type: |
Research
|
| COS Unique Id: |
113216 |
| Title: |
Clinical Trial Award |
| Sponsor: |
United States Department of Defense (DOD)
Department of the Army
U.S. Army Medical Research and Materiel Command (USAMRMC)
Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Medical Research Program (PRMRP)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 4, 2008
|
| Deadline Note: |
Pre-applications are due on June 4, 2008. The deadline for submission of proposals is July 2, 2008. |
| Upper Amount: |
$2,500,000 |
| Amount Note: |
Funding for a Clinical Trial Award can be requested
for up to $2.5 Million for direct costs for up to a four-year
performance period, plus indirect costs as appropriate. |
| Eligibility: |
PIs must be independent investigators at any academic level (or equivalent). |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The Peer Reviewed Medical Research Program (PRMRP)
Clinical Trial Award mechanism is being offered for the first time in
FY08. This award supports rapid implementation of clinical trials of
interventions with the potential to have a significant impact on a
disease or condition addressed in one of the FY08 PRMRP topic areas.
All proposed clinical trials must be responsive to the health care
needs of the Armed Forces and family members, the U.S. Veteran
population, and the general public and may address prevention,
detection, diagnosis, treatment, and/or quality of life. The clinical
trial may be designed to evaluate a pharmacologic agent (drug or
biologic), device, or behavioral intervention. Funding from this award
mechanism cannot be used for preclinical research studies. Each
proposal should contain only one clinical trial with a distinct study
design. Investigational New Drug (IND) or Investigational Device
Exemption (IDE) applications should be submitted or approved prior to
proposal submission.
The FY08 topic areas are Alcoholism
Research, Amyotrophic Lateral Sclerosis, Blood Cancer, Drug Abuse,
Epilepsy Research, Eye and Vision Research, Integrated Tissue Hypoxia
Research, Interstitial Cystitis Inflammatory Bowel Disease,
Leishmaniasis, Lupus, Kidney Cancer, Mesothelioma, Multiple Sclerosis,
Nutrition and Health Promotion Paget's Disease, Polycystic Kidney
Disease, Pulmonary Hypertension, Scleroderma, Social Work Research, and
Tinnitus. |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 619-7079 |
| Contact Fax: |
+1 (301) 619-7792 |
| Contact Email: |
cdmrp.pa@det.amedd.army.mil |
| URL for more information: |
http://cdmrp.army.mil/funding/prmrp.htm |
| Date Last Revised: |
March 31, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113216 |
| Keywords: |
Clinical Trial
Health and Medicine
|
| Sponsor Reference No: |
W81XWH-08-PRMRP-CTA |
| Funding Type: |
Research
|
| COS Unique Id: |
113223 |
| Title: |
Gender, Youth, and HIV Risk (R01) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Child Health and Human Development (NICHD)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
July 29, 2008
|
| Deadline Note: |
A non-required letter of intent is due June 29, 2008. This opportunity will expire on July 30, 2008.
Resubmission and renewal applications are not permitted in response to this FOA. |
| Upper Amount: |
$2,499,990 |
| Amount Note: |
This FOA will utilize the NIH Research Project
Grant (R01) grant mechanism and runs in parallel with a FOA of
identical scientific scope, RFA-HD-08-017, that solicits applications
under the NIH Exploratory/Developmental (R21) grant mechanism. The
total amount of funding that the agency expects to award through this
announcement and the companion FOA 08-017 is $2,000,000; the
anticipated number of awards is six to eight. Budgets for direct costs
of less than $500,000 per year and a project duration of up to five
years may be requested for a maximum of $2,499,990 direct costs over a
five-year project period. Facilities and administrative costs requested
by consortium participants are not included in the direct cost
limitation.
This program does not require cost sharing. |
| Eligibility: |
Eligible applicants include institutions of higher
education; nonprofits, for-profits, and small businesses; state and
local governments; Indian/Native American tribal governments and
tribally designated organizations; U.S. territories or possessions;
regional organizations; eligible agencies of the federal government;
faith-based or community-based organizations; and non-domestic
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
This funding opportunity announcement (FOA) issued
by National Institute of Child Health and Human Development (NICHD),
National Institutes of Health (NIH), solicits Research Project Grant
(R01) applications from institutions and organizations that propose to
study the developmental and environmental processes contributing to HIV
risk in individuals under the age of 24. It calls for studies focusing
on HIV risk in specific settings around the globe where HIV prevalence
is high or increasing and relevant environmental contexts are changing
rapidly.
Responsive applications will focus on a specific aspect
of HIV risk, in a specific cultural or geographic setting, while
integrating understanding of the processes of human development in that
population and of the social environment. The social environment
includes, in addition to structural aspects of the world of youth, the
local understandings of issues related to individuals' behaviors. Both
basic studies and intervention research will be considered.
Research
is specifically needed on two distinct groups of youth who may be most
at risk for exposure to HIV. The first is the unmarried youth -
heterosexual, questioning, and/or homosexual - who are or may be
engaging in a variety of risk behaviors. These are the usual targets of
"teen HIV prevention" studies and they remain an important population
to understand in all their complexity. The second, less often
considered, group is young married women and couples.
Applications
must demonstrate, in specific populations of youth, an understanding of
developmental processes, including gender identity processes and their
responsiveness to context. Studies addressing youths' developmental HIV
risk in the context of changing sociocultural, economic, and
institutional (including health services) environments are of
particular interest. Because these are large challenges, successful
studies need to focus on interactions among well-specified aspects of
the environment or a specific aspect of HIV risk, in a specific
cultural or geographic setting, acknowledging developmental issues in
the population targeted. Any interventions proposed will need to be
grounded in basic social science research as well as in a thorough
understanding of the biological aspects of development and HIV risk in
young populations. Any basic social science research proposed will need
to address the potential for findings that might improve the lives of
young people by reducing their risks of infection. |
| Contact Name: |
Cecilia E. Bruce, Grants Management Specialist |
| Contact Address: |
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 8A17 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 496-1304 |
| Contact Fax: |
+1 (301) 496-4782 |
| Contact Email: |
brucec@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/rfa-files/RFA-HD-08-013.html |
| Date Last Revised: |
March 31, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113223 |
| Keywords: |
AIDS Counseling
HIV
HIV Prevention
|
| Sponsor Reference No: |
RFA-HD-08-013 |
| Funding Type: |
Research
|
| COS Unique Id: |
113227 |
| Title: |
Gender, Youth, and HIV Risk (R21) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
July 29, 2008
|
| Deadline Note: |
A non-required letter of intent is due June 29, 2008. This opportunity will expire on July 30, 2008.
Resubmission and renewal applications are not permitted in response to this FOA. |
| Upper Amount: |
$275,000 |
| Amount Note: |
This FOA will utilize the NIH
Exploratory/Developmental (R21) grant mechanism and runs in parallel
with a FOA of identical scientific scope, RFA-HD-08-013, that solicits
applications under the NIH Research Project Grant (R01) grant
mechanism. The total amount of funding that NICHD expects to award
through this announcement and that of FOA RFA-HD-08-013 is $2,000,000;
the anticipated number of awards is six to eight. NIMH will commit
$400,000 to fund one or two applications under this R21 FOA. The total
project period for an application submitted in response to this funding
opportunity may not exceed two years. Direct costs are limited to
$275,000 over an R21 two-year period, with no more than $200,000 in
direct costs allowed in any single year. Facilities and administrative
costs requested by consortium participants are not included in the
direct cost limitation.
This program does not require cost sharing. |
| Eligibility: |
Eligible applicants include institutions of higher
education; nonprofits, for-profits, and small businesses; state and
local governments; Indian/Native American tribal governments and
tribally designated organizations; U.S. territories or possessions;
regional organizations; eligible agencies of the federal government;
faith-based or community-based organizations; and non-domestic
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
This funding opportunity announcement (FOA) issued
by the National Institute of Child Health and Human Development (NICHD)
and National Institute of Mental Health (NIMH), National Institutes of
Health (NIH), solicits Exploratory/Developmental (R21) applications
from institutions and organizations that propose to study the
developmental and environmental processes contributing to HIV risk in
individuals under the age of 24. It calls for studies focusing on HIV
risk in specific settings around the globe where HIV prevalence is high
or increasing and relevant environmental contexts are changing rapidly.
Responsive
applications will focus on a specific aspect of HIV risk, in a specific
cultural or geographic setting, while integrating understanding of the
processes of human development in that population and of the social
environment. The social environment includes, in addition to structural
aspects of the world of youth, the local understandings of issues
related to individuals' behaviors. Both basic studies and intervention
research will be considered.
Research is specifically needed on
two distinct groups of youth who may be most at risk for exposure to
HIV. The first is the unmarried youth - heterosexual, questioning,
and/or homosexual - who are or may be engaging in a variety of risk
behaviors. These are the usual targets of "teen HIV prevention" studies
and they remain an important population to understand in all their
complexity. The second, less often considered, group is young married
women and couples.
Applications must demonstrate, in specific
populations of youth, an understanding of developmental processes,
including gender identity processes and their responsiveness to
context. Studies addressing youths' developmental HIV risk in the
context of changing sociocultural, economic, and institutional
(including health services) environments are of particular interest.
Because these are large challenges, successful studies need to focus on
interactions among well-specified aspects of the environment or a
specific aspect of HIV risk, in a specific cultural or geographic
setting, acknowledging developmental issues in the population targeted.
Any interventions proposed will need to be grounded in basic social
science research as well as in a thorough understanding of the
biological aspects of development and HIV risk in young populations.
Any basic social science research proposed will need to address the
potential for findings that might improve the lives of young people by
reducing their risks of infection.
Additional Contact:
Rita Sisco, Supervisory Grants Management Specialist
DHHS/NIH/NIMH/DEA/GRB
6001 Executive Boulevard, Room 6120
Rockville Maryland 20892-9605
Phone +1 (301) 443-2805
Fax +1 (301) 443-6885
siscor@mail.nih.gov |
| Contact Name: |
Cecilia E. Bruce, Grants Management Specialist |
| Contact Address: |
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 8A17 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 496-1304 |
| Contact Fax: |
+1 (301) 496-4782 |
| Contact Email: |
brucec@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/rfa-files/RFA-HD-08-017.html |
| Date Last Revised: |
March 31, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113227 |
| Keywords: |
AIDS Counseling
HIV
HIV Prevention
|
| Sponsor Reference No: |
RFA-HD-08-017 |
| Funding Type: |
Research
|
| COS Unique Id: |
113238 |
| Title: |
Gene and Genome Synthesis and Assembly (Synthetic Biology) |
| Sponsor: |
ITI Scotland Ltd.
ITI Life Sciences
|
| Sponsor Type: |
Commercial |
| Deadline: |
May 5, 2008
|
| Amount Note: |
As a general guide for this type of opportunity,
ITI Life Sciences usually commissions programmes in the range of £2-5
million ($4-10 million) with an average lifetime of 18-36 months.
However, because several research partners maybe involved, funding of
individual work packages may be lower. |
| Eligibility: |
ITI Life Sciences invites responses from companies,
agencies, institutes, consortia, academia and individuals. No
geographical restrictions apply and ITI welcomes responses to this call
from non-UK organisations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Academic Institution
|
| Abstract: |
ITI Life Sciences, a division of ITI Scotland Ltd.,
focuses on driving innovation in the life sciences sector. ITI Life
Sciences seeks to fund research and development opportunities that will
contribute to an innovative gene and genome synthesis and assembly
programme. ITI wishes to discuss innovative responses that seek to
achieve this goal by addressing some or all of the key activities
relating to gene and genome synthesis and assembly. ITI is also
interested in the use of enabling technologies arising from other
fields such as microfluidics. Key activities relating to gene and
genome synthesis and assembly include (but are not limited to) assembly
strategy design, oligonucleotide synthesis, oligonucleotide
purification, genome assembly, and error detection and reduction
strategies and methods. |
| Contact Name: |
Sr. Analyst, Technology and Markets |
| Contact Address: |
ITI Life Sciences
Innovation House
17 Luna Place
Dundee Technology Park |
| Contact City: |
Dundee |
| Contact Zip: |
DD2 1TP |
| Contact Country: |
United Kingdom |
| Contact Phone: |
+44 (0) 1382-568060 |
| Contact Fax: |
+44 (0) 1382-568061 |
| Contact Email: |
nicolas.peyret@itilifesciences.com |
| URL for more information: |
http://www.itilifesciences.co.uk/syb/ |
| Date Last Revised: |
April 1, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113238 |
| Keywords: |
Biosynthesis
Genes
Genomics
|
| Funding Type: |
Research
|
| COS Unique Id: |
113241 |
| Title: |
Research Programme Funding |
| Sponsor: |
ITI Scotland Ltd.
ITI Life Sciences
|
| Sponsor Type: |
Commercial |
| Deadline Note: |
Continuous. The first step in the application
procedure is submission of a proposal outline (three-five pages). The
purpose is to enable us initially to assess the eligibility and
feasibility of the research programme based on the criteria outlined
below, and should be seen as a discussion document rather than a formal
application. After the review process those proposals of interest are
invited for further discussion. |
| Amount Note: |
Successful programmes tend to be funded in the range of £0.5-5 million and last two to three years. |
| Eligibility: |
ITI Life Sciences welcomes research programme
proposals from industry and academia. There is no geographical
restriction for applicants or their programme collaborators. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Academic Institution
|
| Abstract: |
ITI Life Sciences, a division of ITI Scotland Ltd.,
focuses on driving innovation in the life sciences sector. ITI Life
Sciences will consider proposals to commission pre-competitive
market-driven research programmes that ultimately stimulate
entrepreneurial activity in Scotland.
ITI Life Sciences is currently investigating several areas of technology, and welcome interest in these areas.
-
Emerging Drug Targets: ITI are interested in opportunities that may
arise due to the changing understanding of cell signaling mechanisms
and pathways. Such opportunities may include drug target discovery, new
chemical entity discovery, novel diagnostics, or reagents for the life
sciences research markets.
- Molecular Imaging: Initial findings
suggest that the following opportunities exist: (1) Tracer development:
exploitation of current tracers in other applications and the
development of novel tracers; and (2) Technological Innovations in new
modalities and improving the performance of current modalities,
particularly in combining modalities for improved R&D efficiency or
clinical diagnosis.
- Monoclonal Antibodies: Having examined the
next generation of monoclonal antibody technologies, ITI are keen to
explore the potential of mab fragments and scaffolds in applications
such as molecular imaging (as potential tracers) and protein arrays
(diagnostics and research tools).
- Nanomedicine and Biofuels:
While these are interesting areas, they are not current priorities for
ITI Life Sciences, though ITI is maintaining a watch on these areas and
is interested in receiving proposals related to their findings.
ITI Life Sciences has identified the following new areas of foresighting.
-
Synthetic Biology: This term covers the application of engineering and
computer science to genomic circuits to construct small biological
devices. These processes or products have a vast reach and may include
alternative energy sources, new vaccines and novel pharmaceuticals.
-
Non-invasive and minimally invasive medical technologies: Reflecting a
growing trend towards less invasiveness, ITI is interested in a range
of technologies in this space covering diagnosis and treatment of
disease. This may cover diverse areas from image guided surgery, real
time continuous monitoring and laser therapy to retinal scanning. |
| Contact Address: |
ITI Life Sciences
Innovation House
17 Luna Place
Dundee Technology Park |
| Contact City: |
Dundee |
| Contact Zip: |
DD2 1TP |
| Contact Country: |
United Kingdom |
| Contact Phone: |
+44 (0) 1382-568060 |
| Contact Fax: |
+44 (0) 1382-568061 |
| Contact Email: |
email@itilifesciences.com |
| URL for more information: |
http://www.itilifesciences.com/defaultpage131cd0.aspx?pageID=733 |
| Date Last Revised: |
April 1, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113241 |
| Keywords: |
Biomass Fuels
Biotechnology
Drug Design
Life Sciences
Molecular Biology
Nanostructured Materials
Pharmaceuticals
|
| Funding Type: |
Research
|
| COS Unique Id: |
113278 |
| Title: |
Exploratory/Developmental Grant for Complementary and Alternative Medicine (CAM) Studies of Humans (R21) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 16, 2008
October 16, 2008
February 16, 2009
|
| Deadline Note: |
The opening date is May 16, 2008. This opportunity will expire on May 8, 2011. |
| Upper Amount: |
$400,000 |
| Amount Note: |
This award will use the R21 grant mechanism. The
total project period for an application submitted in response to this
funding opportunity may not exceed three years. Direct costs are
limited to $400,000 over an R21 three-year period, with no more than
$250,000 in direct costs allowed in any single year. The R21 is not
renewable.
This program does not require cost sharing. |
| Eligibility: |
Eligible applicants include institutions of higher
education; nonprofits, for-profits, and small businesses; state and
local governments; Indian/Native American tribal governments and
tribally designated organizations; U.S. territories or possessions;
regional organizations; eligible agencies of the federal government;
faith-based or community-based organizations; and non-domestic
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The National Center for Complementary and
Alternative Medicine (NCCAM), the National Cancer Institute (NCI), the
National Institute on Aging (NIA), and the Office of Dietary
Supplements (ODS) invite high quality exploratory/developmental
research grant applications of humans in all domains of complementary
and alternative medicine (CAM), in order to obtain preliminary data
that can be used as a foundation for a larger clinical study.
NCCAM
groups CAM practices into four domains: biologically-based practices;
energy medicine; manipulative and body-based therapies; and mind-body
medicine. In addition, NCCAM funds studies of whole medical systems
that employ practices drawn from the four domains.
One of the
primary missions of NCCAM is to advance CAM science. Understanding the
safety, efficacy, and effectiveness of CAM approaches may facilitate
their integration into conventional health care practices. However,
prior to conducting clinical trials to determine definitively efficacy
and effectiveness, there is important information that needs to be
generated. A variety of study designs (e.g., observational, case
control, cohort studies, randomized clinical studies) may be used to
obtain this information. Additionally, qualitative research may be used
to the extent that it uniquely and significantly contributes to the
knowledge base supporting future clinical investigations. Thus, an
important goal of this exploratory/developmental research grant
solicitation is to provide independent investigators, at all career
levels, with the opportunity to design pilot and small investigations
using a variety of rigorous study designs that will build a sound
empirical base for future clinical investigations. The selection of
study design will depend on the question being addressed and must be
justified by the investigator in the application.
The NCI
shares NCCAM's interest in research applications that focus on
complementary and alternative medical approaches related to the
prevention, diagnosis, and treatment of cancer. The NCI also invites
high quality exploratory/developmental clinical research grant
applications that focus on CAM approaches related to cancer symptoms
and side-effects of cancer treatment as well as survivorship.
Applications related to bioactive food components in the domain of
translational nutritional sciences should identify molecular targeting
efficiencies of a single or a combination of nutrients and/or bioactive
foods component(s) which could protect against the development of
cancer. It is anticipated that these pilot R21 studies will generate
supporting preliminary clinical data that can be used to support larger
clinical studies.
The NIA shares NCCAM's interest in research
applications that focus on complementary and alternative medical
approaches related to the prevention, diagnosis, and treatment of
health conditions in the elderly. The NIA also invites high quality
exploratory/developmental clinical research grant applications that
focus on CAM approaches related to the improvement of subjective
well-being in older people. It is anticipated that these pilot R21
studies will generate supporting preliminary data that can be used to
support larger studies.
Additional Contacts:
1. Jeffrey White, M.D., Director
Office of Cancer Complementary and Alternative Medicine
National Cancer Institute
6116 Executive Boulevard, Suite 609, MSC 7302
Bethesda, MD 20892-7302
Phone +1 (301) 435-7980
Fax +1 (301) 480-0075
jeffreyw@mail.nih.govs
2. Lisbeth Nielsen, Ph.D.
Program Director, Psychological Development and Integrative Science
Behavioral and Social Research Program
National Institute on Aging
7201 Wisconsin Avenue, #533
Bethesda, MD 20892
Phone +1 (301) 402-4156
Fax +1 (301) 402-0051
nielsenli@nia.nih.gov |
| Contact Name: |
April Bower, R.N., M.S., Health Program Specialist |
| Contact Address: |
Division of Extramural Research
National Center for Complementary and Alternative Medicine
6707 Democracy Blvd., Suite 401 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 451-3560 |
| Contact Fax: |
+1 (301) 480-3621 |
| Contact Email: |
bowera@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PAR-08-135.html |
| Date Last Revised: |
April 3, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113278 |
| Keywords: |
Alternative Medicine
|
| Sponsor Reference No: |
PAR-08-135 |
| Funding Type: |
Research
|
| COS Unique Id: |
113295 |
| Title: |
Medical Research Grants |
| Sponsor: |
Progeria Research Foundation
|
| Sponsor Type: |
Private Foundation |
| Deadline: |
August 7, 2008
|
| Deadline Note: |
Grant applications will be accepted and considered
two times per year. The Board of Directors will consider proposals at
their second and fourth quarterly meeting of the calendar year,
typically held in May/June and November/December. |
| Amount Note: |
Projects will ordinarily be funded for a period of
one to two years. Under exceptional circumstances, funding will be
continued for a third or fourth year of the project. Grant awards will
be provided in amounts up to $50,000 per year. Overhead or indirect
costs will not be allowed. |
| Eligibility: |
Principal investigators must hold postdoctoral
positions or beyond. Awards will be granted only to applicants
affiliated with institutions with 501(c)3 status, or the equivalent for
foreign institutions. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The foundation awards grants to applicants who seek
to conduct research to find the cause, treatment, or cure for
Hutchinson-Gilford Progeria Syndrome (HGPS). |
| Contact Address: |
The Progeria Research Foundation
Grants Division
P.O. Box 3453 |
| Contact City: |
Peabody |
| Contact State: |
Massachusetts |
| Contact Zip: |
01961-3453 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (978) 535-2594 |
| Contact Fax: |
+1 (978) 535-5849 |
| Contact Email: |
info@progeriaresearch.org |
| URL for more information: |
http://www.progeriaresearch.org/grant_application.html |
| Date Last Revised: |
April 4, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113295 |
| Keywords: |
Genetic Diseases
|
| Funding Type: |
Research
|
| COS Unique Id: |
21131 |
| Title: |
Science, Technology, and Society (STS) - NSF 08-553 |
| Sponsor: |
National Science Foundation (NSF)
Directorate for Social, Behavioral, and Economic Sciences (SBE)
Division of Social and Economic Sciences (SES)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
August 1, 2008
February 1, 2009
|
| Deadline Note: |
The full proposal target dates are August 1, 2008,
and February 1, 2009. SGTR proposals may only be submitted by the
August target date for consideration in the fall of each year. |
| Amount Note: |
Projects duration for Scholars Awards is up to
three years. The maximum award (indirect costs excluded) is normally
$180,000. Proposals of longer duration or requesting larger amounts of
support will be considered if extraordinarily well justified and
merited. STS Scholars Awards may provide support for full-time academic
year (nine months) research, including salary, fringe benefits, and
other direct costs, up to a ceiling that is ordinarily $90,000 for
total direct costs. Proposals may also request support for full-time
summer research, including salary, fringe benefits, and other direct
costs, up to approximately $20,000 for total direct costs. Summer
salary request may not exceed two months of academic year salary.
Annual limit for project support in a 12-month period is normally
$110,000, exclusive of indirect costs. Research assistance may also be
requested but must be justified in the proposal's work plan. Normal
limits for such support are $8,000 per year for an undergraduate
research assistant, $18,000 per year for a graduate student and $50,000
per year (including fringe benefits) for a designated postdoctoral
researcher. Indirect costs assessed by institutions will be added to
these levels of support.
Generally the maximum award for
Standard and Collaborative Grants, excluding indirect costs, is
$400,000 for an award of two to three years' duration. Proposals of
longer duration, or proposals requesting larger amounts of support,
will be considered if extraordinarily well justified and merited.
Indirect costs assessed by institutions will be added to these levels
of support.
Postdoctoral Fellowships normally provide an annual
stipend of up to $50,000 (including fringe benefits) per year for
support of full-time academic year study and research. Postdoctoral
Fellowships allow research and travel expenses of up to $5,000 per
year. The proposal should justify expenditure of the research and
travel expenses. Postdoctoral Fellowships provide a fixed-amount
institutional allowance of $5,000 per year in lieu of indirect costs.
(NSF will not pay the institutional allowance to non-U.S.
institutions.) There are no dependents' allowances, and moving
expenses, if requested, must be deducted from the research and travel
allowance. The maximum award normally will be $60,000 per year. Awards
may be for up to two years.
The annual stipend for Professional
Development Fellowships depends upon the fellow's current salary and
work history, and can range from $50,000 to $90,000, inclusive of
fringe benefits, for a full-time academic year of study and research
(or half-time over two years) in a field outside the fellow's current
area of expertise. These awards provide $5,000 for travel and research
expenses. The budget should justify these expenditures; moving expenses
(if requested) must be deducted from the travel allowance. These
fellowships provide a fixed-amount institutional allowance of $5,000
per year in lieu of indirect costs.
Doctoral Dissertation
Research Improvement Grants provide funds for dissertation research
expenses not normally available through the student's university.
Awards are not intended to cover the full costs of a student's doctoral
dissertation research. Funds may be used only for valid research
expenses that include, but are not limited to, conducting field
research in settings away from campus that would not otherwise be
possible, data collection and sample survey costs, payments to subjects
or informants, specialized research equipment, analysis and services
not otherwise available, supplies, travel to archives, special
collections or seminars, and facilities or field research locations,
and partial living expenses for conducting necessary research away from
the student's university. Funds are to be used exclusively for the
actual conduct of dissertation research. These funds may not be used as
a student stipend, for tuition, textbooks, journals, or for the typing,
reproduction, or publication costs of the student's dissertation. Funds
may be requested for research assistants only in very special
circumstances, which should be carefully justified. The usual limit on
a dissertation award is $10,000 for research in North America. The
usual limit for international research is $15,000. No indirect costs
are allowed.
STS may only fund two or three SGTRs each year.
These awards provide a maximum of $130,000 per year, exclusive of
indirect costs, to support one postdoctoral fellow and up to three
graduate students to participate each year. For projects of more than
one year, PIs may retain or change the postdoc and graduate students.
These awards are made to the university. The budget for student and
postdoc support belongs in the personnel section of the budget form.
Indirect costs can be applied to these budget items.
STS
normally limits support for conferences and workshops to $25,000.
Expenses (travel, stipends, honoraria, etc.) for attendees should be
entered on the Participant Support line of the budget. These expenses
are not eligible for indirect costs. |
| Eligibility: |
Scholars Awards are normally made to U.S. academic
institutions, although an individual who is not affiliated with an
appropriate U.S. academic institution may submit a proposal as an
independent scholar. In that case, the scholar must be a U.S. citizen
or national, or have permanent resident status.
Standard and Collaborative Grants are made to U.S. academic institutions.
Postdoctoral
Fellowships are available for STS researchers within five years of
receipt of the Ph.D. degree. Fellows must be U.S. citizens or
nationals, or have permanent resident status. The host faculty member
at the host institution normally should be listed as the Principal
Investigator (PI). The fellow generally prepares the proposal and
normally should be listed as the co-PI. The host institution usually
submits the proposal and administers the award. In certain
circumstances (such as when the fellowship takes place at an
institution outside the United States), Postdoctoral Fellows may submit
proposals as independent PIs.
Professional Development Fellows must be U.S. citizens or nationals, or have permanent resident status.
Doctoral
students who are enrolled in U.S. graduate programs are eligible to
apply for the Doctoral Dissertation Research Improvement Grants. The
dissertation advisor is the principal investigator. Doctoral students
must have passed the qualifying exams, completed all course work
required for the degree, and had the dissertation topic approved prior
to receiving the award.
SGTR awards are available for STS
postdoctoral researchers within five years of receipt of the Ph.D. and
for graduate students who are regularly admitted students in STS
graduate programs. All postdoctoral fellows must be U.S. citizens or
nationals, or have permanent resident status. The host faculty at the
sponsoring institution should submit and administer the award. The host
institution must provide letters agreeing to provide appropriate space
and facilities, and applications should also include letters from
institutional administrators indicating their support of the initiative. |
| Citizenship or Residency: |
United States
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
Academic Institution
|
| Abstract: |
STS considers proposals that examine historical,
philosophical, and sociological questions that arise in connection with
science, engineering, and technology, and their respective interactions
with society. STS has four components:
1. Ethics and Values in Science, Engineering, and Technology (EVS)
2. History and Philosophy of Science, Engineering, and Technology (HPS)
3. Social Studies of Science, Engineering, and Technology (SSS)
4. Studies of Policy, Science, Engineering, and Technology (SPS)
The
components overlap, but are distinguished by the different scientific
and scholarly orientations they take to the subject matter, as well as
by different focuses within the subject area. STS encourages the
submission of hybrid proposals that strive to integrate research
involving two or more of these core areas.
STS provides the following modes of support:
1. Scholars Awards
2. Standard Research Grants and Grants for Collaborative Research
3. Postdoctoral Fellowships
4. Professional Development Fellowships
5. Doctoral Dissertation Research Improvement Grants
6. Small Grants for Training and Research (SGTR)
7. Conference and Workshop Awards
8. Other Funding Opportunities
NSF 08-553 replaces NSF 05-588.
CFDA 47.075 |
| Contact Name: |
Frederick M. Kronz, Program Officer |
| Contact Address: |
National Science Foundation
Directorate for Social, Behavioral, and Economic Sciences
Division of Social and Economic Sciences
4201 Wilson Boulevard, Room 995 N |
| Contact City: |
Arlington |
| Contact State: |
Virginia |
| Contact Zip: |
22230 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (703) 292-7283 |
| Contact Email: |
fkronz@nsf.gov |
| URL for more information: |
http://www.nsf.gov/pubs/2008/nsf08553/nsf08553.htm |
| Date Last Revised: |
April 2, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=21131 |
| Keywords: |
General Science and Technology Topics
History of Science and Technology
Research Methodology
Science and Society
Science Communication
Science Planning or Policy
Sociology of Science
Technology
Technology Planning or Policy
Technology Transfer
|
| Sponsor Reference No: |
NSF 08-553 |
| Funding Type: |
Collaboration or Cooperative Agreement
Meeting or Conference or Seminar
Training, Scholarship, or Fellowship
Postdoctoral Award
Research
Dissertation or Thesis
|
| COS Unique Id: |
92838 |
| Title: |
Flagship Collaborative Research Program |
| Sponsor: |
Commonwealth Scientific and Industrial Research Organisation (CSIRO) - Australia
|
| Sponsor Type: |
Other Nonprofit |
| Deadline Note: |
Varies. Potential applicants for projects and
clusters must discuss proposals with the relevant Flagship before
proposals are drafted. This will minimise the opportunity and other
costs associated with preparing unsuccessful full applications.
Applications
for solicited Flagship projects will be required by the closing dates
nominated on the Flagship website. Applications for unsolicited
Flagship projects will be accepted at any time, but an expression of
interest is required ahead of the full proposal to ensure it is aligned
with Flagship objectives.
The next round of Flagship cluster
proposals will be advertised in early 2008, for clusters commencing in
early 2009. Please note that universities and other organisations may
require applications to be submitted for internal review at least 10
days ahead of the external closing date. |
| Upper Amount: |
$40,000 |
| Amount Note: |
Flagship projects will be of limited duration and
focused on a specific outcome. The level of funding must be sufficient
to ensure impact on the Flagship program. In normal circumstances, it
is envisaged that projects would attract funding of around $100,000 per
year from the Fund, up to a maximum of $200,000 for two years. Flagship
clusters will be funded for approximately three years at around $1
million from the Flagship Collaboration Fund per year, with at least
equivalent co-investment of cash and/or in-kind support by the partner
institutions/organisations expected. Flagship clusters have been
accepted for inclusion on the Australian Competitive Grants Register. |
| Eligibility: |
Applications for projects and clusters will be
accepted from publicly-funded research institutions, both in Australia
and overseas. This includes universities, Cooperative Research Centres
(CRCs), other Australian PFRAs (excluding CSIRO) and other publicly
funded and not-for-profit research institutions. Industry partners are
welcome to participate in clusters, however they are not eligible to
receive funding from the Flagship Collaboration Fund.
Each cluster must include at least one Australian university. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Government
Nonprofit
Academic Institution
|
| Abstract: |
In April 2003 the Prime Minister Mr. John Howard,
launched the Commonwealth Science and Industrial Research Organisation
(CSIRO) Flagship Initiative. Flagships were developed through extensive
consultation with government, with CSIRO partners in science and
industry, and with opinion leaders in the community.
Flagships
are targeted at six national goals, which are closely aligned to the
Commonwealth Government's National Research Priorities. Each flagship
involves collaboration between leading Australian scientists, research
institutions, commercial companies and CSIRO. Their scale, longer
time-frames, and clear focus on delivery and adoption of research
outputs are designed to maximise their impact in key areas of economic
and community need.
The six flagship programs and their goals are as follows:
1.
Preventative Health - To improve the health and well-being of
Australians and save $2 billion in annual direct health costs by 2020
through the prevention and early detection of chronic diseases
2.
Light Metals - To lead a global revolution in light metals, doubling
export income and generating significant new industries for Australia
by the 2020s while reducing environmental impact
3. Food Futures -
To transform the international competitiveness and add $3 billion
annually to the Australian agrifood sector by the application of
frontier technologies to high-potential industries
4. Energy
Transformed - To halve greenhouse gas emissions and double the
efficiency of the nation's new energy generation, supply, and end use,
and to position Australia for a future hydrogen economy
5. Water
for a Healthy Country - To achieve a tenfold increase in the social,
economic, and environmental benefits from water by 2025
6. Wealth
From Oceans - To position Australia by 2020 as an international
benchmark in the delivery of economic, social, and environmental wealth
based on leadership in understanding ocean systems and processes
Additional
government funding for the National Research Flagships initiative was
announced in May 2007, supporting the creation of three new Flagships:
1. Climate Adaptation
2. Minerals Down Under
3. Niche Manufacturing
In the Commonwealth Government announcement on the Backing Australia's Ability - Building Our Future Through Science and Innovation
package, a further $305 million was committed to the CSIRO Flagship
Initiative over seven years to reinforce the development of
collaborative research partnerships which reflect the National Research
Priorities.
Of the $305 milliion, $96.8 million was set aside
to form the Flagship Collaboration Fund - a contestable funding pool
designed to further strengthen collaboration between the Flagships,
universities and other publicly-funded research institutions. The
components of this funding pool are
- a collaborative research program (supporting projects and "clusters");
- visiting fellowships; and
- postgraduate scholarships.
Part
of the additional funding for the Flagship initiative announced in 2007
was also set aside to expand the Flagship Collaboration Fund, taking
the total amount to approximately $114 million over seven years. These
guidelines detail the principles for the allocation of funding for the
two elements of the collaborative research program.
The
Flagship Collaboration Fund provides a new mechanism for enhancing
collaboration and facilitating the involvement of the broader research
community in addressing the ambitious goals targeted by the Flagship
initiative. Funding is specifically to be used by partner organisations
to enhance the overall effort in the Flagship initiative by either
increasing scale and focus or bringing together complementary
expertise. An important underlying principle is that the funds must
support the directions of the Flagships and must align with their
strategic goals and outcomes.
Flagship projects will be funded
to support a specific research project that has outcomes and
deliverables relevant to a Flagship objective. This approach is based
on the US Defense Advanced Research Projects Agency (DARPA) funding
model of focusing on specific project outcomes and their delivery.
Projects can stem from ideas generated from within CSIRO where there is
a specific need to engage outside expertise to help achieve a
particular Flagship objective - these are called solicited projects.
This expertise may come in the form of intellectual capital, comprising
people and intellectual property, or physical capital and
infrastructure, including facilities and equipment.
Solicited
projects will be advertised when required. Universities and other
research organisations will be notified when project specifications
have been published. Researchers are encouraged to apply for funding
for these projects if they believe they have the necessary
complementary expertise to achieve the Flagship objective. Often new
and innovative ideas will originate from outside organisations which
have the potential to further the objectives of a Flagship - those that
are accepted into Flagships are called unsolicited projects.
Researchers seeking support under the Flagship Collaboration Fund for
unsolicited projects should explore fully the Flagships' interests in
research by reviewing the material on the Flagships website. Projects
that do not have direct relevance to the strategic goals and outcomes
of a Flagship will not be supported.
Project proposals may be
submitted by a single organisation or a number of organisations.
Project leaders will normally be employed by the organisation leading
the development of the application.
Flagship clusters will be
funded to support a larger scale of activity over approximately three
years with an emphasis on people and partnerships working on a stream
of research relevant to a Flagship. A Flagship cluster may involve the
co-location of staff of CSIRO and partner organisations to enhance the
exchange of ideas and complementary expertise between the two groups,
similar to the Intel open collaborative model of industry-university
research. Joint projects will be proposed and initiated by CSIRO and/or
external partner staff located in the cluster during its life, and
these will be expected to deliver outcomes relevant to a Flagship theme
or stream objective, with co-investment by both organisations being a
key factor.
Cluster leaders play a central role in the
coordination of cluster activity and reporting to the Flagship Director
and will normally be employed by the organisation leading the
development of the cluster application. Cluster leaders are supported
by a cluster management committee, which serves as a focal point for
collaboration between the partners. (Additional support for cluster
leaders can be included in budget proposals and provided from the
fund.)
Additional Contact:
Ms. Sue Kingsland, Executive Officer, Flagship Operations
CSIRO P.O. Box 225
Dickson ACT 2602 Australia
Phone: +61 (02) 6276-6258
Fax +61 (02) 6276-6273
Sue.Kingsland@csiro.au |
| Contact Name: |
Mr. John Williams, General Manager, Flagship Operations |
| Contact Address: |
CSIRO
P.O. Box 225 |
| Contact City: |
Dickson |
| Contact State: |
Australian Capital Territory |
| Contact Zip: |
2602 |
| Contact Country: |
Australia |
| Contact Phone: |
+61 (02) 9490-8229 |
| Contact Fax: |
+61 (02) 6276-6273 |
| Contact Email: |
John.M.Williams@csiro.au |
| URL for more information: |
http://www.csiro.au/csiro/content/file/pf4w,,.html |
| Date Last Revised: |
April 3, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=92838 |
| Keywords: |
Agribusiness
Alternative Fuels
Energy Conservation
Energy Efficiency
Energy Engineering
Energy Planning or Policy
Energy Sciences
Food Marketing
Food Sciences
Food Technology
Health Promotion
Marine and Ocean Sciences
Marine Engineering
Materials Sciences
Metallurgical Engineering
Metallurgy
Metals or Alloys
Preventive Medicine
Public Health
Water Quality
Water Resources Engineering
|
| Funding Type: |
Collaboration or Cooperative Agreement
Research
|
|
|
©2008, ProQuest LLC All rights reserved
|
|
